Publications that describe laboratory-based research accomplishments to facilitate the development of new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of FDA-regulated products.  Nominations must have an FDA staff member as the first or last author on the manuscript which must have been accepted or published in a reputable, peer reviewed journal in the last fiscal year.

2023
Tony T. Wang, Ph.D. (Senior Staff Fellow - CBER)
Shufeng Liu, Ph.D. (Staff Fellow - CBER)
Prabhuanand Selvaraj, Ph.D. (Contractor - CBER)
Charles Brandon Stauft, Ph.D. (Staff Fellow - CBER) 

For a paper describing an invention of a genetic approach to attenuate SARS-CoV-2 to facilitate COVID-19 vaccine research and review.

Journal Name: Nature Communications